University of Tennessee Medical Center Heart, Lung, Vascular Institute and
The University of Tennessee Graduate School of Medicine
November 3-4, 2017
University of Tennessee Conference Center
Screening methods and interventions are available, but underutilized, in the treatment of heart failure, abdominal aortic aneurysm (AAA), congestive heart failure (CHF), anti-coagulation, and hypertension. For example, heart failure affects an estimated 5.7 million patients in the United States with 870,000 new cases occur annually. Fifty percent of patients die within five years of diagnosis. Only forty-one percent of patients with the diagnosis of heart failure are prescribed the guidelines-based combination of ACE-Inhibitor, beta blocker, and mineralocorticoid therapy, a combination proven to improve mortality.
Only one percent of Medicare recipients eligible for screening for AAA receive this screening. The U.S. Preventive Services task force released guidelines for AAA screening in 2014, upon which the Medicare eligibility guidelines (documented to be underutilized above) were based.
The FDA approved sacubitril-valsartan for the treatment of CHF in July of 2015, however only 40,000 patients of the eligible 2.8 million received the drug in 2016. The 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure awarded sacubitril-valsartan a class 1, level of evidence B indication of CHF with reduced LVEF.
The Heart, Lung, Vascular Update will aid participants in the ability to recognize patients eligible for treatment and initiate these therapies and screening tests.
Healthcare professionals practicing in:
At the conclusion of this program, the participant should be able to
|Early||After October 1||After October 27|
|Physician & Pharmacist||$200||$225||$250|
|Non-Physician & Non-Pharmacist||$150||$175||$200|
|Physician & Pharmacist||$150||$175||$200|
|Non-Physician & Non-Pharmacist||$100||$125||$150|
|Physician & Pharmacist||$100||$125||$150|
|Non-Physician & Non-Pharmacist||$50||$75||$100|
To qualify for a refund on conference registration fees, send a written request by October 27, 2017, to UT Conferences, ATTN: HLV 2017, P.O. Box 2648, Knoxville, TN 37901-2648, or to Conferences@utk.edu. An administrative fee of $50 will be assessed. No-shows and late cancellations will not be refunded; however, substitutions are encouraged.
Download the UT Conference Center map or contact our office 865-974-0280 for assistance. Download Map
Room Reservations at Knoxville Hilton Downtown
(501 W. Church Avenue, Knoxville, TN 37902)
Thursday, November 2: $96, plus tax
- Friday and Saturday, November 3-4: $214, plus tax
(14-day cancellation policy)
Group Code: HLVC
Reservations: (865) 251-2573 or reserve online
Deadline: October 15 or until block is full
AMA:. The University of Tennessee College of Medicine designates this live activity for a maximum of 10 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PAs, NPs, and Nurses: Physician Assistants, Nurse Practitioners, and Nurses may use these credit hours toward certification renewal. This credit is acceptable by the American Academy of Physician's Assistants (AAPA), American Nurses Credentialing Association (ANCC) and American Academy of Nurse Practitioners (AANP).
Friday: The University of Tennessee College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Successful completion of this application-based activity will provide a statement for six and a half (6.5) live contact hours credit (0.65 CEUs) and will be mailed within 3 weeks following the activity. Successful completion includes attending the session, signing the attendance sheet, and completion of the activity evaluation form.UAN: 0064-9999-17-054-L01-P
Saturday: The University of Tennessee College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Successful completion of this application-based activity will provide a statement for three and a half (3.5) live contact hours credit (0.35 CEUs) and will be mailed within 3 weeks following the activity. Successful completion includes attending the session, signing the attendance sheet, and completion of the activity evaluation form.UAN: 0064-9999-17-055-L01-P
NABP e-PROFILE ID NUMBER: Your CE credits will also be submitted electronically to NABP. Pharmacists or pharmacy technicians with questions regarding their NABP e-Profile or CPE Monitor should refer to the FAQ section on the NABP website: www.nabp.net/programs/cpe-monitor/cpemonitor-service. To receive credit for your participation in this course, all pharmacists must include their NABP e-Profile ID number, along with their month and date of birth. If incorrect information is provided, this will result in “rejected” status from the CPE Monitor. It is the responsibility of the participant to notify The University of Tennessee (within the 60-day submission timeframe) of their corrected information. Otherwise, the completed CE will not be accepted by the CPE Monitor.
Grievance Policy: A participant, provider, faculty member or other individual wanting to file a grievance with respect to any aspect of an activity provided or co-provided by the UTCOP may contact the Associate Dean for Continuing Education in writing. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.
The University of Tennessee Graduate School of Medicine
1924 Alcoa Highway
Knoxville, Tennessee 37920 | 865-305-9290
Copyright © 2018